- Home
- NTIC vs EPRX Comparison
NTIC vs EPRX Comparison
Compare NTIC & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIC
- EPRX
- Stock Information
- Founded
- NTIC 1970
- EPRX 2011
- Country
- NTIC United States
- EPRX Canada
- Employees
- NTIC N/A
- EPRX N/A
- Industry
- NTIC Industrial Specialties
- EPRX
- Sector
- NTIC Industrials
- EPRX
- Exchange
- NTIC Nasdaq
- EPRX NYSE
- Market Cap
- NTIC 106.3M
- EPRX 109.7M
- IPO Year
- NTIC N/A
- EPRX N/A
- Fundamental
- Price
- NTIC $11.17
- EPRX $3.65
- Analyst Decision
- NTIC Buy
- EPRX Strong Buy
- Analyst Count
- NTIC 1
- EPRX 1
- Target Price
- NTIC $20.00
- EPRX $9.00
- AVG Volume (30 Days)
- NTIC 15.6K
- EPRX 15.8K
- Earning Date
- NTIC 04-10-2025
- EPRX 03-04-2025
- Dividend Yield
- NTIC 2.51%
- EPRX N/A
- EPS Growth
- NTIC 52.91
- EPRX N/A
- EPS
- NTIC 0.52
- EPRX N/A
- Revenue
- NTIC $86,216,235.00
- EPRX N/A
- Revenue This Year
- NTIC $8.16
- EPRX N/A
- Revenue Next Year
- NTIC $10.97
- EPRX N/A
- P/E Ratio
- NTIC $21.48
- EPRX N/A
- Revenue Growth
- NTIC 7.59
- EPRX N/A
- 52 Week Low
- NTIC $10.96
- EPRX $2.20
- 52 Week High
- NTIC $19.63
- EPRX $4.08
- Technical
- Relative Strength Index (RSI)
- NTIC 34.79
- EPRX N/A
- Support Level
- NTIC $11.11
- EPRX N/A
- Resistance Level
- NTIC $12.53
- EPRX N/A
- Average True Range (ATR)
- NTIC 0.40
- EPRX 0.00
- MACD
- NTIC 0.05
- EPRX 0.00
- Stochastic Oscillator
- NTIC 13.38
- EPRX 0.00
About NTIC Northern Technologies International Corporation
Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.